Digestive Drugs Market, By Type (Branded and Generic), By Drug Class (5-aminosalicylates, GI stimulants, Laxatives, Antacids, H2 Antagonists, Antidiarrheals, Others), By Route of Administration (Oral, Intravenous, Others), By Application (Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome, Ulcerative Colitis, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Digestive drugs are used to relieve gastrointestinal symptoms such as acid reflux, indigestion, and irritable bowel syndrome (IBS) among others. In addition, it is also used to treat other severe conditions such as Crohn's disease, ulcerative colitis, and hiatal hernia. The common digestive system diseases include symptoms such as abdominal pain, bloating, diarrhoea, constipation and heartburn. There are various gastrointestinal therapeutics that are used for treating various gastrointestinal conditions. For instance, acid reflux and indigestion are treated with antacids such as ranitidine and omeprazole. More severe conditions like ulcerative colitis and Crohn's disease are treated with medications such as budesonide, mesalazine and prednisolone. Few key market players manufacturing gastrointestinal drugs includes AbbVie, Alexion Pharmaceuticals, GlaxoSmithKline, Ironwood Pharmaceuticals and Janssen Pharmaceuticals among others.
Market Dynamics
Companies operating in digestive drugs market are launching new drugs which is contributing to growth of the digestive drugs market. For instance, in July 2022, JW Pharmaceutical, a South Korea based pharmaceutical company, launched Besticon a compound digestive medicine. It is composed of alverine citrate, simethicone and antispasmodic agent. Besticon is effective for patients suffering with irritable bowel syndrome, indigestion and other gastrointestinal issues. Similarly, in May 2021, Bristol Myers Squibb, a multinational pharmaceutical company received the U.S. Food and Drug Administration (FDA) approval for Zeposia for the treatment of severely active ulcerative colitis (UC). It is a sphingosine 1-phosphate (S1P) receptor modulator which reduces lymphocyte migration into the intestines.
Key features of the study:
- This report provides an in-depth analysis of the global digestive drugs market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global digestive drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include GlaxoSmithKline plc, AbbVie Inc. (Allergan), Takeda Pharmaceutical Company Limited, Pfizer Inc, AstraZeneca plc, Marksans Pharma, Tillotts Pharma AG, Salix Pharmaceuticals, Otsuka Pharmaceutical Co., Ltd., Merck & Co., Inc., Lexicon Pharmaceuticals, Inc., Bayer AG, Cadila Healthcare Ltd.
- Global digestive drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global digestive drugs market
- Global Digestive Drugs Market, By Type
- Branded
- Generic
- Global Digestive Drugs Market, By Drug Class
- 5-aminosalicylates
- GI stimulants
- Laxatives
- Antacids
- H2 Antagonists
- Antidiarrheals
- Others
- Global Digestive Drugs Market, By Route of Administration
- Oral
- Intravenous
- Others
- Global Digestive Drugs Market, By Application
- Gastroesophageal Reflux Disease (GERD)
- Irritable Bowel Syndrome
- Ulcerative Colitis
- Others (Chronic diarrhoea, constipation etc.)
- Global Digestive Drugs Market, By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Global Digestive Drugs Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
- Company Profiles
- GlaxoSmithKline plc*
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AbbVie Inc. (Allergan)
- Takeda Pharmaceutical Company Limited
- Pfizer Inc
- AstraZeneca plc
- Marksans Pharma
- Tillotts Pharma AG
- Salix Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd.
- Merck & Co., Inc.
- Lexicon Pharmaceuticals, Inc.
- Bayer AG
- Cadila Healthcare Ltd.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Drug Class
- Market Snapshot, By Route of Administration
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Market Trends
- New Product Launches
- Regulatory Scenario
- PORTER’s Five Forces Analysis
- Business Development Strategies
- Epidemiology
- Disease Awareness Programs
- Treatment Safety and Efficacy Analysis
- Pipeline Analysis
- 4. Global Digestive Drugs Market– Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact on Healthcare
- Impact on Digestive Drugs Manufacturing and Its Market Demand
- COVID-19 Epidemiology
- 5. Global Digestive Drugs Market, By Type, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Generic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 6. Global Digestive Drugs Market, By Drug Class, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- 5-aminosalicylates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- GI stimulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Antacids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- H2 Antagonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Antidiarrheals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 7. Global Digestive Drugs Market, By Route of Administration, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 8. Global Digestive Drugs Market, By Application, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Gastroesophageal Reflux Disease (GERD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Irritable Bowel Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Ulcerative Colitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Others (Chronic diarrhoea, constipation etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 9. Global Digestive Drugs Market, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 – 2030
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2030, (US$ Mn)
- 10. Global Digestive Drugs Market, By Region, 2017 – 2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2030, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- 11. Competitive Landscape
- Market Share Analysis
- GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AbbVie Inc. (Allergan)
- Takeda Pharmaceutical Company Limited
- Pfizer Inc
- AstraZeneca plc
- Marksans Pharma
- Tillotts Pharma AG
- Salix Pharmaceuticals
- Otsuka Pharmaceutical Co., Ltd.
- Merck & Co., Inc.
- Lexicon Pharmaceuticals, Inc.
- Bayer AG
- Cadila Healthcare Ltd.
- Analyst Views
- 12. Section
- Research Methodology
- About us
- *Browse 67 market data tables and 85 figures on "Global Digestive Drugs Market” - forecast to 2030
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook